microdose compounded semaglutide (Injections) – Immortals Compounded Semaglutide Microdoses - Weight

By activating GLP-1 receptors in the brain, semaglutide sends signals that promote feelings of fullness and reduce the desire to overeat

Its premise is an upstream intervention targeting substantial weight reduction to improve key risk factors with the aim to avoid potential downstream complications from multiple co-morbidities, e.g., hypertension, dyslipidaemia, heart failure, kidney disease, NAFLD/NASH or diabetes

In another study, participants were placed on a low-carbohydrate diet after stopping the medication, and the researchers reported that they maintained their weight loss

Most HSA/FSA plans should cover this, but check with your provider to confirm

Step 4: Prescription Fulfillment and Delivery